![]() |
|
|
Vol. 59, Issue 3, 524-531, March 2001
Department of Molecular Physiology, National Cardiovascular Center
Research Institute, Osaka, Japan (T.I., S.K., Y.I., Y.T., M.S.); and
Department of Physiology, School of Medicine, Fukuoka University,
Fukuoka, Japan (A.U., I.I.)
KB-R7943 (2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea
methanesulfonate) is a potent and selective
Na+/Ca2+ exchange (NCX) inhibitor that is
3-fold more inhibitory to NCX3 than to NCX1 or NCX2. Here we searched
for amino acid residues that may form the KB-R7943 receptor in the
exchanger by analyzing the function of chimeras between NCX1 and NCX3
as well as of their site-directed mutants. We found that the highly
conserved
-2 repeat of the exchanger is almost exclusively
responsible for the difference in drug response of the isoforms. Such
difference was mostly reproduced by single substitutions of residues in
the
-2 repeat (V820G or Q826V in NCX1 and A809V or A809I in NCX3), suggesting their importance in drug sensitivity. Cysteine scanning mutagenesis of the
-2 repeat of NCX1 identified one residue (Gly833) that caused a large (
30-fold) reduction in drug sensitivity. We
found that the Gly-to-Thr substitution caused even larger reduction in
drug sensitivity. Interestingly, extracellularly applied KB-R7943 at
0.8 µM markedly inhibited the whole-cell outward exchange current, whereas the drug applied intracellularly at 30 µM did not. These results suggest that KB-R7943 inhibits the exchanger from the external
side in intact cells and that a region of the
-2 repeat of NCX1
containing Gly833 may participate in the formation of the drug
receptor. Because we suggested previously that Gly833 is accessible
from the inside of a cell, the results raised an interesting
possibility that this residue may alter its position during
Na+/Ca2+ exchange in such a way that it becomes
accessible to external drug.
This article has been cited by other articles:
![]() |
T. Iwamoto and S. Kita YM-244769, a Novel Na+/Ca2+ Exchange Inhibitor That Preferentially Inhibits NCX3, Efficiently Protects against Hypoxia/Reoxygenation-Induced SH-SY5Y Neuronal Cell Damage Mol. Pharmacol., December 1, 2006; 70(6): 2075 - 2083. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawada, T. Yamazaki, T. Akiyama, K. Uemura, A. Kamiya, T. Shishido, H. Mori, and M. Sugimachi Effects of Ca2+ channel antagonists on nerve stimulation-induced and ischemia-induced myocardial interstitial acetylcholine release in cats Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2187 - H2191. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwamoto Vascular Na+/Ca2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R536 - R545. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dipolo and L. Beauge Sodium/Calcium Exchanger: Influence of Metabolic Regulation on Ion Carrier Interactions Physiol Rev, January 1, 2006; 86(1): 155 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Beauge and R. DiPolo SEA-0400, a potent inhibitor of the Na+/Ca2+ exchanger, as a tool to study exchanger ionic and metabolic regulation Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1374 - C1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, J. X.-J. Yuan, K. E. Barrett, and H. Dong Role of Na+/Ca2+ exchange in regulating cytosolic Ca2+ in cultured human pulmonary artery smooth muscle cells Am J Physiol Cell Physiol, February 1, 2005; 288(2): C245 - C252. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Annunziato, G. Pignataro, and G. F. Di Renzo Pharmacology of Brain Na+/Ca2+ Exchanger: From Molecular Biology to Therapeutic Perspectives Pharmacol. Rev., December 1, 2004; 56(4): 633 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwamoto, Y. Inoue, K. Ito, T. Sakaue, S. Kita, and T. Katsuragi The Exchanger Inhibitory Peptide Region-Dependent Inhibition of Na+/Ca2+ Exchange by SN-6 [2-[4-(4-Nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic Acid Ethyl Ester], a Novel Benzyloxyphenyl Derivative Mol. Pharmacol., July 1, 2004; 66(1): 45 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bouchard, A. Omelchenko, H. D. Le, P. Choptiany, T. Matsuda, A. Baba, K. Takahashi, D. A. Nicoll, K. D. Philipson, M. Hnatowich, et al. Effects of SEA0400 on Mutant NCX1.1 Na+-Ca2+ Exchangers with Altered Ionic Regulation Mol. Pharmacol., March 1, 2004; 65(3): 802 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwamoto, S. Kita, A. Uehara, I. Imanaga, T. Matsuda, A. Baba, and T. Katsuragi Molecular Determinants of Na+/Ca2+ Exchange (NCX1) Inhibition by SEA0400 J. Biol. Chem., February 27, 2004; 279(9): 7544 - 7553. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Miyata, D. P. Zipes, S. Hall, and M. Rubart KB-R7943 Prevents Acute, Atrial Fibrillation-Induced Shortening of Atrial Refractoriness in Anesthetized Dogs Circulation, September 10, 2002; 106(11): 1410 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Reuter, S. A. Henderson, T. Han, T. Matsuda, A. Baba, R. S. Ross, J. I. Goldhaber, and K. D. Philipson Knockout Mice for Pharmacological Screening: Testing the Specificity of Na+-Ca2+ Exchange Inhibitors Circ. Res., July 26, 2002; 91(2): 90 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Elias, A. Lukas, S. Shurraw, J. Scott, A. Omelchenko, G. J. Gross, M. Hnatowich, and L. V. Hryshko Inhibition of Na+/Ca2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1334 - H1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J Conway and S. V Koushik Cardiac sodium-calcium exchanger: a double-edged sword Cardiovasc Res, August 1, 2001; 51(2): 194 - 197. [Full Text] [PDF] |
||||
![]() |
M. Shigekawa and T. Iwamoto Cardiac Na+-Ca2+ Exchange : Molecular and Pharmacological Aspects Circ. Res., May 11, 2001; 88(9): 864 - 876. [Abstract] [Full Text] [PDF] |
||||